High-Power Targets: Experience and R&D for 2 MW

High-power particle production targets are crucial elements of future neutrino and other rare particle beams. Fermilab plans to produce a beam of neutrinos (LBNE) with a 2.3 MW proton beam (Project X). Any solid target is unlikely to survive for an extended period in such an environment - many materials would not survive a single beam pulse. We are using our experience with previous neutrino and antiproton production targets, along with a new series of R&D tests, to design a target that has adequate survivability for this beamline. The issues considered are thermal shock (stress waves), heat removal, radiation damage, radiation accelerated corrosion effects, physics/geometry optimization and residual radiation

Synchrotron radiation based beam diagnostics at the Fermilab Tevatron

Synchrotron radiation has been used for many years as a beam diagnostic at electron accelerators. It is not normally associated with proton accelerators as the intensity of the radiation is too weak to make detection practical. However, if one utilizes the radiation originating near the edge of a bending magnet, or from a short magnet, the rapidly changing magnetic field serves to enhance the wavelengths shorter than the cutoff wavelength, which for more recent high energy proton accelerators such as Fermilab's Tevatron, tends to be visible light. This paper discusses the implementation at the Tevatron of two devices. A transverse beam profile monitor images the synchrotron radiation coming from the proton and antiproton beams separately and provides profile data for each bunch. A second monitor measures the low-level intensity of beam in the abort gaps which poses a danger to both the accelerator's superconducting magnets and the silicon detectors of the high energy physics experiments. Comparisons of measurements from the profile monitor to measurements from the flying wire profile systems are presented as are a number of examples of the application of the profile and abort gap intensity measurements to the modelling of Tevatron beam dynamics

Long-Baseline Neutrino Facility (LBNF) and Deep Underground Neutrino Experiment (DUNE) Conceptual Design Report Volume 2: The Physics Program for DUNE at LBNF

The Physics Program for the Deep Underground Neutrino Experiment (DUNE) at the Fermilab Long-Baseline Neutrino Facility (LBNF) is described

Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma

<p>Abstract</p> <p>Background</p> <p>To evaluate the metabolic changes in urinary steroids in pre- and post-menopausal women and men with papillary thyroid carcinoma (PTC).</p> <p>Methods</p> <p>Quantitative steroid profiling combined with gas chromatography-mass spectrometry was used to measure the urinary concentrations of 84 steroids in both pre- (n = 21, age: 36.95 ± 7.19 yr) and post-menopausal female (n = 19, age: 52.79 ± 7.66 yr), and male (n = 16, age: 41.88 ± 8.48 yr) patients with PTC. After comparing the quantitative data of the patients with their corresponding controls (pre-menopause women: n = 24, age: 33.21 ± 10.48 yr, post-menopause women: n = 16, age: 49.67 ± 8.94 yr, male: n = 20, age: 42.75 ± 4.22 yr), the levels of steroids in the patients were normalized to the mean concentration of the controls to exclude gender and menopausal variations.</p> <p>Results</p> <p>Many urinary steroids were up-regulated in all PTC patients compared to the controls. Among them, the levels of three active androgens, androstenedione, androstenediol and 16α-hydroxy DHEA, were significantly higher in the pre-menopausal women and men with PTC. The corticoid levels were increased slightly in the PTC men, while progestins were not altered in the post-menopausal PTC women. Estrogens were up-regulated in all PTC patients but 2-hydroxyestrone and 2-hydroxy-17β-estradiol were remarkably changed in both pre-menopausal women and men with PTC. For both menopausal and gender differences, the 2-hydroxylation, 4-hydroxylation, 2-methoxylation, and 4-methoxylation of estrogens and 16α-hydroxylation of DHEA were differentiated between pre- and post-menopausal PTC women (<it>P </it>< 0.001). In particular, the metabolic ratio of 2-hydroxyestrone to 2-hydroxy-17β-estradiol, which could reveal the enzyme activity of 17β-hydroxysteroid dehydrogenase, showed gender differences in PTC patients (<it>P </it>< 1 × 10^-7).</p> <p>Conclusions</p> <p>These results are expected be helpful for better understanding the pathogenic differences in PTC according to gender and menopausal conditions.</p